Dysregulated pH: A perfect storm for cancer progression

Nature Reviews Cancer

Volumn 11, Issue 9, 2011, Pages 671-677

  Webb, Bradley A ^a   Chimenti, Michael ^a   Jacobson, Matthew P ^a   Barber, Diane L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; BREAST CANCER RESISTANCE PROTEIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; GELATINASE B; GUANOSINE TRIPHOSPHATASE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOENOLPYRUVATE; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GLYCOLYSIS; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH SENSOR; PRIORITY JOURNAL; REVIEW; SENSOR;

ACID-BASE IMBALANCE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 81155159685     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3110     Document Type: Review

References (116)

1. Hanahan, D. & Weinberg, R.A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
2. Gillies, R.J., Raghunand, N., Karczmar, G.S. & Bhujwalla, Z.M. MRI of the tumor microenvironment. J.Magn. Reson. Imaging 16, 430-450 (2002). (Pubitemid 35167878)
3. Stüwe, L. et al. pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution. J.Physiol. 585, 351-360 (2007). (Pubitemid 350193911)
4. Busco, G. et al. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J. 24, 3903-3915 (2010).
5. Gallagher, F.A. et al. Magnetic resonance imaging of pH invivo using hyperpolarized 13C-labelled bicarbonate. Nature 453, 940-943 (2008). (Pubitemid 351832568)
6. Martinez-Zaguilan, R., Lynch, R.M., Martinez, G.M. & Gillies, R.J. Vacuolar-type H+-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J.Physiol. 265, C1015-C1029 (1993).
7. Sennoune, S.R. et al. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am. J.Physiol. Cell Physiol. 286, C1443-C1452 (2004). (Pubitemid 38649995)
8. Hinton, A. et al. Function of a subunit isoforms of the V-ATPase in pH homeostasis and invitro invasion of MDA-MB231 human breast cancer cells. J.Biol. Chem. 284, 16400-16408 (2009).
9. McLean, L.A., Roscoe, J., Jorgensen, N.K., Gorin, F.A. & Cala, P.M. Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am. J.Physiol. Cell Physiol. 278, C676-C688 (2000). (Pubitemid 30211300)
10. Kumar, A.P. et al. Repression of NHE1 expression by PPARγ activation is a potential new approach for specific inhibition of the growth of tumor cells invitro and invivo. Cancer Res. 69, 8636-8644 (2009).
11. Miraglia, E. et al. Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin. Int. J.Cancer 115, 924-929 (2005). (Pubitemid 40791833)
12. Chiang, Y., Chou, C.-Y., Hsu, K.F., Huang, Y.F. & Shen, M.R. EGF upregulates Na+/H+ exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness. J.Cell. Physiol. 214, 810-819 (2008). (Pubitemid 351224226)
13. Pinheiro, C. et al. Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. Int. J.Gynecol. Pathol. 27, 568-574 (2008).
14. Pinheiro, C. et al. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch. 452, 139-146 (2008).
15. Pinheiro, C. et al. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J.Biomed. Biotechnol. 2010, 427694 (2010).
16. Kennedy, K.M. & Dewhirst, M.W. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol. 6, 127-148 (2010).
17. Chiche, J. et al. Invivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. Int. J.Cancer 30May 2011 (doi:10.1002/ijc.26125).
18. Halestrap, A.P. & Price, N.T. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343, 281-299 (1999). (Pubitemid 29511759)
19. Harris, T., Eliyahu, G., Frydman, L. & Degani, H. Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells. Proc. Natl Acad. Sci. USA 106, 18131-18136 (2009).
20. Denker, S.P. & Barber, D.L. Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J.Cell Biol. 159, 1087-1096 (2002). (Pubitemid 36055762)
21. Patel, H. & Barber, D.L. A developmentally regulated Na-H exchanger in Dictyostelium discoideum is necessary for cell polarity during chemotaxis. J.Cell Biol. 169, 321-329 (2005). (Pubitemid 40656569)
22. Grillon, E. et al. The spatial organization of proton and lactate transport in a rat brain tumor. PLoS ONE 6, e17416 (2011).
23. Martin, C., Pedersen, S.F., Schwab, A. & Stock, C. Intracellular pH gradients in migrating cells. Am. J.Physiol. Cell Physiol. 300, C490-C495 (2011).
24. Wykoff, C.C. et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60, 7075-7083 (2000). (Pubitemid 32059187)
25. Loncaster, J.A. et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61, 6394-6399 (2001). (Pubitemid 32783244)
26. Swietach, P., Patiar, S., Supuran, C.T., Harris, A.L. & Vaughan-Jones, R.D. The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growths. J.Biol. Chem. 284, 20299-20310 (2009).
27. Chiche, J. et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 69, 358-368 (2009).
28. Ilie, M. et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br. J.Cancer 102, 1627-1635 (2010).
29. Pastorekova, S., Parkkila, S. & Zavada, J. Tumor-associated carbonic anhydrases and their clinical significance. Adv. Clin. Chem. 42, 167-216 (2006). (Pubitemid 44302109)
30. Cardone, R.A., Casavola, V. & Reshkin, S.J. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nature Rev. Cancer 5, 786-795 (2005). (Pubitemid 41400778)
31. Harguindey, S., Orive, G., Luis Pedraz, J., Paradiso, A. & Reshkin, S.J. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim. Biophys. Acta 1756, 1-24 (2005). (Pubitemid 41317557)
32. Gatenby, R.A., Gawlinski, E.T., Gmitro, A.F., Kaylor, B. & Gillies, R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66, 5216-5223 (2006). (Pubitemid 43844945)
33. Stock, C. & Schwab, A. Protons make tumor cells move like clockwork. Pflugers Arch. 458, 981-992 (2009).
34. Srivastava, J., Barber, D.L. & Jacobson, M.P. Intracellular pH sensors: design principles and functional significance. Physiology 22, 30-39 (2007).
35. Pouyssigur, J., Franchi, A., L'Allemain, G. & Paris, S. Cytoplasmic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts. FEBS Lett. 190, 115-119 (1985). (Pubitemid 16251330)
36. Moolenaar, W.H. Effects of growth factors on intracellular pH regulation. Annu. Rev. Physiol. 48, 363-376 (1986). (Pubitemid 16047621)
37. Kapus, A., Romanek, R., Qu, A.Y., Rotstein, O.D. & Grinstein, S. A pH-sensitive and voltage-dependent proton conductance in the plasma membrane of macrophages. J.Gen. Physiol. 102, 729-760 (1993). (Pubitemid 23328153)
38. Denker, S.P., Huang, D.C., Orlowski, J., Furthmayr, H. & Barber, D.L. Direct binding of the Na-H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H+ translocation. Mol. Cell 6, 1425-1436 (2000). (Pubitemid 32045934)
39. Lagadic-Gossmann, D., Huc, L. & Lecureur, V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 11, 953-961 (2004). (Pubitemid 39232355)
40. Matsuyama, S. Llopis, J., Deveraux, Q.L., Tsien, R.Y. & Reed, J.C. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nature Cell Biol. 2, 318-325 (2000).
41. Putney, L.K. & Barber, D.L. Na-H exchange-dependent increase in intracellular pH times G2/M entry and transition. J.Biol. Chem. 278, 44645-44649 (2003). (Pubitemid 37377220)
42. Harada, K., Oita, E. & Chiba, K. MetaphaseI arrest of starfish oocytes induced via the MAP kinase pathway is released by an increase of intracellular pH. Development 130, 4581-4586 (2003). (Pubitemid 37279411)
43. Sellier, C. et al. Intracellular acidification delays hormonal G2/M transition and inhibits G2/M transition triggered by thiophosphorylated MAPK in Xenopus oocytes. J.Cell. Biochem. 98, 287-300 (2006).
44. Park, H.J., Lyons, J.C., Ohtsubo, T. & Song, C.W. Cell cycle progression and apoptosis after irradiation in an acidic environment. Cell Death Differ. 7, 729-738 (2000). (Pubitemid 30601340)
45. Zhao, R. et al. DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH. PLoS Biol. 5, e1 (2007).
46. Liao, C., Hu, B., Arno, M.J. & Panaretou, B. Genomic screening invivo reveals the role played by vacuolar H+ ATPase and cytosolic acidification in sensitivity to DNA-damaging agents such as cisplatin. Mol. Pharmacol. 71, 416-425 (2007). (Pubitemid 46147908)
47. Khaled, A.R., Kim, K., Hofmeister, R., Muegge, K. & Durum, S.K. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl Acad. Sci. USA 96, 14476-14481 (1999). (Pubitemid 30000675)
48. Gatenby, R.A. & Gillies, R.J. Why do cancers have high aerobic glycolysis? Nature Rev. Cancer 4, 891-899 (2004). (Pubitemid 39472955)
49. Tennant, D.A., Durαn, R.V. & Gottlieb, E. Targeting metabolic transformation for cancer therapy. Nature Rev. Cancer 10, 267-277 (2010).
50. Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13, 472-482 (2008). (Pubitemid 351766797)
51. Vander Heiden, M.G., Cantley, L.C. & Thompson, C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
52. Kuwata, F. et al. Enzymatic regulation of glycolysis and gluconeogenesis in rabbit periodontal ligament under various physiological pH conditions. J.Nihon Univ. Sch. Dent. 33, 81-90 (1991).
53. al-Habori, M., Peak, M., Thomas, T.H. & Agius, L. The role of cell swelling in the stimulation of glycogen synthesis by insulin. Biochem. J. 282, 789-796 (1992).
54. Dietl, K. et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J.Immunol. 184, 1200-1209 (2010).
55. Gray, J.A. Kinetics of enamel dissolution during formation of incipient caries-like lesions. Arch. Oral Biol. 11, 397-422 (1966).
56. Trivedi, B. & Danforth, W.H. Effect of pH on the kinetics of frog muscle phosphofructokinase. J.Biol. Chem. 241, 4110-4112 (1966).
57. Frieden, C., Gilbert, H.R. & Bock, P.E. Phosphofructokinase III. Correlation of the regulatory kinetic and molecular properties of the rabbit muscle enzyme. J.Biol. Chem. 251, 5644-5647 (1976).
58. Andrés, V., Carreras, J. & Cussó, R. Regulation of muscle phosphofructokinase by physiological concentrations of bisphosphorylated hexoses: effect of alkalinization. Biochem. Biophys. Res. Commun. 172, 328-334 (1990). (Pubitemid 20352540)
59. Banaszak, K. et al. The crystal structures of eukaryotic phosphofructokinases from baker's yeast and rabbit skeletal muscle. J.Mol. Biol. 407, 284-297 (2011).
60. Schering, B., Eigenbrodt, E., Linder, D. & Schoner, W. Purification and properties of pyruvate kinase type M2 from rat lung. Biochim. Biophys. Acta 717, 337-347 (1982).
61. Akhtar, K. et al. Differential behavior of missense mutations in the intersubunit contact domain of the human pyruvate kinase M2 isozyme. J.Biol. Chem. 284, 11971-11981 (2009).
62. Christofk, H.R., Vander Heiden, M.G., Wu, N., Asara, J.M. & Cantley, L.C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452, 181-186 (2008). (Pubitemid 351380242)
63. Hitosugi, T. et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2, ra73 (2009).
64. Deberardinis, R.J., Sayed, N., Ditsworth, D. & Thompson, C.B. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18, 54-61 (2008).
65. Putney, L. & Barber, D. Expression profile of genes regulated by activity of the Na-H exchanger NHE1. BMC Genomics 5, 46 (2004).
66. Chen, J.L. et al. The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet. 4, e1000293 (2008).
67. Attanasio, F. et al. Novel invadopodia components revealed by differential proteomic analysis. Eur. J.Cell Biol. 90, 115-127 (2011).
68. Campanella, M.E., Chu, H. & Low, P.S. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc. Natl Acad. Sci. USA 102, 2402-2407 (2005). (Pubitemid 40279388)
69. Chu, H. & Low, P.S. Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3. Biochem. J. 400, 143-151 (2006). (Pubitemid 44763829)
70. Van Horssen, R. et al. Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity. J.Biol. Chem. 284, 1620-1627 (2009).
71. Frantz, C., Karydis, A., Nalbant, P., Hahn, K.M. & Barber, D.L. Positive feedback between Cdc42 activity and H+ efflux by the Na-H exchanger NHE1 for polarity of migrating cells. J.Cell Biol. 179, 403-410 (2007). (Pubitemid 350074786)
72. Koivusalo, M. et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J.Cell Biol. 188, 547-563 (2010).
73. Frantz, C. et al. Cofilin is a pH sensor for actin free barbed end formation: role of phosphoinositide binding. J.Cell Biol. 183, 865-879 (2008).
74. Pope, B.J., Zierler-Gould, K.M., Kühne, R., Weeds, A.G. & Ball, L.J. Solution structure of human cofilin: actin binding, pH sensitivity, and relationship to actin-depolymerizing factor. J.Biol. Chem. 279, 4840-4848 (2004). (Pubitemid 38199079)
75. McLachlan, G.D., Cahill, S.M., Girvin, M.E. & Almo, S.C. Acid-induced equilibrium folding intermediate of human platelet profilin. Biochemistry 46, 6931-6943 (2007). (Pubitemid 46906422)
76. Moseley, J.B. et al. Twinfilin is an actin-filament-severing protein and promotes rapid turnover of actin structures invivo. J.Cell Sci. 119, 1547-1557 (2006). (Pubitemid 43732981)
77. Grey, M.J. et al. Characterizing a partially folded intermediate of the villin headpiece domain under non-denaturing conditions: contribution of His41 to the pH-dependent stability of the N-terminal subdomain. J.Mol. Biol. 355, 1078-1094 (2006). (Pubitemid 43012149)
78. Srivastava, J. et al. Structural model and functional significance of pH-dependent talin-actin binding for focal adhesion remodeling. Proc. Natl Acad. Sci. USA 105, 14436-14441 (2008).
79. Lee, H.-S. et al. Characterization of an actin-binding site within the talin FERM domain. J.Mol. Biol. 343, 771-784 (2004). (Pubitemid 39311621)
80. Goldmann, W.H., Hess, D. & Isenberg, G. The effect of intact talin and talin tail fragment on actin filament dynamics and structure depends on pH and ionic strength. Eur. J.Biochem. 260, 439-445 (1999). (Pubitemid 29122540)
81. Schmidt, J.M., Zhang, J., Lee, H.S., Stromer, M.H. & Robson, R.M. Interaction of talin with actin: sensitive modulation of filament crosslinking activity. Arch. Biochem. Biophys. 366, 139-150 (1999). (Pubitemid 29394239)
82. Sidani, M. et al. Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. J.Cell Biol. 179, 777-791 (2007). (Pubitemid 350146261)
83. van Rheenen, J., Condeelis, J. & Glogauer, M. A common cofilin activity cycle in invasive tumor cells and inflammatory cells. J.Cell Sci. 122, 305-311 (2009).
84. Lee, S.A. et al. Targeting of the FYVE domain to endosomal membranes is regulated by a histidine switch. Proc. Natl Acad. Sci. USA 102, 13052-13057 (2005). (Pubitemid 41324977)
85. Wymann, M.P. & Schneiter, R. Lipid signalling in disease. Nature Rev. Mol. Cell Biol. 9, 162-176 (2008). (Pubitemid 351158917)
86. Stock, C. et al. Protons extruded by NHE1: digestive or glue? Eur. J.Cell Biol. 87, 591-599 (2008).
87. Stock, C. et al. Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange. J.Physiol. 567, 225-238 (2005). (Pubitemid 41167317)
88. Karydis, A., Jimenez-Vidal, M., Denker, S.P. & Barber, D.L. Mislocalized scaffolding by the Na-H exchanger NHE1 dominantly inhibits fibronectin production and TGF-β activation. Mol. Biol. Cell 20, 2327-2336 (2009).
89. Paradise, R.K., Lauffenburger, D.A. & Van Vliet, K.J. Acidic extracellular pH promotes activation of integrin αvβ3. PLoS ONE 6, e15746 (2011).
90. Martin, N.K., Gaffney, E.A., Gatenby, R.A. & Maini, P.K. Tumour-stromal interactions in acid-mediated invasion: a mathematical model. J.Theor. Biol. 267, 461-470 (2010).
91. Saadoun, S., Papadopoulos, M.C., Hara-Chikuma, M. & Verkman, A.S. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 434, 786-792 (2005). (Pubitemid 44739524)
92. Charras, G.T., Yarrow, J.C., Horton, M.A., Mahadevan, L. & Mitchison, T.J. Non-equilibration of hydrostatic pressure in blebbing cells. Nature 435, 365-369 (2005). (Pubitemid 40745547)
93. Rozhin, J., Sameni, M., Ziegler, G. & Sloane, B.F. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54, 6517-6525 (1994).
94. Johnson, L.L. et al. A rationalization of the acidic pH dependence for stromelysin-1 (Matrix metalloproteinase-3) catalysis and inhibition. J.Biol. Chem. 275, 11026-11033 (2000). (Pubitemid 30212742)
95. Wilhelm, S.M. et al. Matrix metalloproteinase-3 (stromelysin-1). Identification as the cartilage acid metalloprotease and effect of pH on catalytic properties and calcium affinity. J.Biol. Chem. 268, 21906-21913 (1993). (Pubitemid 23320695)
96. Bourguignon, L.Y. W., Singleton, P.A., Diedrich, F., Stern, R. & Gilad, E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J.Biol. Chem. 279, 26991-27007 (2004). (Pubitemid 38812535)
97. Giusti, I. et al. Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia 10, 481-488 (2008). (Pubitemid 351657390)
98. Robey, I.F. et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 69, 2260-2268 (2009).
99. Gerweck, L.E., Vijayappa, S. & Kozin, S. Tumor pH controls the invivo efficacy of weak acid and base chemotherapeutics. Mol. Cancer Ther. 5, 1275-1279 (2006). (Pubitemid 43881320)
100. Mahoney, B.P., Raghunand, N., Baggett, B. & Gillies, R.J. Tumor acidity, ion trapping and chemotherapeutics: I. acid pH affects the distribution of chemotherapeutic agents invitro. Biochem. Pharmacol. 66, 1207-1218 (2003). (Pubitemid 37130296)
101. Raghunand, N., Mahoney, B.P. & Gillies, R.J. Tumor acidity, ion trapping and chemotherapeutics: II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem. Pharmacol. 66, 1219-1229 (2003). (Pubitemid 37130297)
102. Thews, O., Gassner, B., Kelleher, D.K., Schwerdt, G. & Gekle, M. Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8, 143-152 (2006).
103. Frizard, F., Pereira-Maia, E., Quidu, P., Priebe, W. & Garnier-Suillerot, A. P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine. Eur. J.Biochem. 268, 1561-1567 (2001). (Pubitemid 32862688)
104. Aller, S.G. et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323, 1718-1722 (2009).
105. Breedveld, P. et al. The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in invitro drug transport models. Mol. Pharmacol. 71, 240-249 (2007). (Pubitemid 46020994)
106. Du, J.-Z., Sun, T.M., Song, W.J., Wu, J. & Wang, J. A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. Angew. Chem. Int. Ed. Engl. 49, 3621-3626 (2010).
107. Ahmed, F. et al. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol. Pharm. 3, 340-350 (2006). (Pubitemid 44021440)
108. Li, W., Nicol, F. & Szoka, F.C. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev. 56, 967-985 (2004). (Pubitemid 38520204)
109. Bae, Y., Fukushima, S., Harada, A. & Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. Engl. 42, 4640-4643 (2003). (Pubitemid 37271305)
110. Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869-873 (2010).
111. DiGiammarino, E.L. et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nature Struct. Biol. 9, 12-16 (2002).
112. Iwakuma, T. & Lozano, G. Crippling p53 activities via knock-in mutations in mouse models. Oncogene 26, 2177-2184 (2007). (Pubitemid 46536640)
113. Olive, K.P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847-860 (2004). (Pubitemid 40017690)
114. Pouyssigur, J., Franchi, A. & Pagθs, G. pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. Novartis Found. Symp. 240, 186-196 (2001). (Pubitemid 33603787)
115. Reshkin, S.J. et al. Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 14, 2185-2197 (2000).
116. Matthews, H., Ranson, M. & Kelso, M.J. Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call of duty? Int. J.Cancer 4May 2011 (doi:10.1002/ijc.26156).